Enalaprilat 51662-1477
Product NDC
51662-1477- Manufacturer
- Hf Acquisition Co Llc, Dba Healthfirst
- Dosage Form
- Injection
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- February 1, 2020
- Listing Expires
- December 31, 2026
- Application
- ANDA078687
Need to source Enalaprilat? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Enalaprilat | 1.25 mg/mL |
Drug Class
Angiotensin Converting Enzyme Inhibitor [EPC]Angiotensin-converting Enzyme Inhibitors [MoA]Decreased Blood Pressure [PE]
Packaging Options(1)
1 mL in 1 VIAL (51662-1477-1)